De Santana C F, Da Silva I N
Rev Inst Antibiot (Recife). 1974 Dec;14(1-2):3-8.
Preliminary results of active immunotherapy ,both in vitro and in vivo, about ascitical Ehrlich carcinoma transplanted in albinic swiss mice are presented. In the in vitro experiment, tumor cells were marked with the immunoglobulin, anti-tumor-associated antigens (TAA) and were coupled to a dinitrophenyl radical (Ig DNP anti-TAA). These cells were meaningfully hindered from migration in presence of swiss albinic mice's splenic cells. These mice were sensibilized to the tumor cells marked with Ig-DNP. The injection of a Ig-DNP anti-TAA 0,3 ml, every third days, intraperitoneal way, in a span of 21 days, in albinical swiss mice with a transplant of 3 X 10(5) Ehrlich carcinoma cells (group A) 24 hours before, constituted the in vivo test. The growth ought to be compared to an Ig-DNP tolerant group (group B), which received equal quantities of tumor cells and followed the same plan of treatment, as well as to another control group transplanted under the same conditions, but with no treatment (group C). Eight days from the experiment, there was a clear difference between group A and groups B and C. The last two groups died from 13th to the 26th day after the transplant. On the contrary, the whore group A continued alive and with no sign of ascitical tumor. Nevertheless, an animal of group A died after the 28th day, due to a solid tumor in the abdominal wall.
本文展示了对白化瑞士小鼠移植的艾氏腹水癌进行体内外主动免疫治疗的初步结果。在体外实验中,肿瘤细胞用免疫球蛋白、抗肿瘤相关抗原(TAA)进行标记,并与二硝基苯基基团偶联(Ig DNP抗TAA)。在瑞士白化小鼠脾细胞存在的情况下,这些细胞的迁移受到显著抑制。这些小鼠对用Ig-DNP标记的肿瘤细胞产生了致敏作用。在移植3×10⁵个艾氏癌细胞(A组)24小时前,以腹腔注射的方式,每三天给白化瑞士小鼠注射0.3 ml Ig-DNP抗TAA,持续21天,构成体内试验。其生长情况应与Ig-DNP耐受组(B组)进行比较,B组接受等量的肿瘤细胞并遵循相同的治疗方案,同时与在相同条件下移植但未接受治疗的另一个对照组(C组)进行比较。实验八天后,A组与B组和C组之间存在明显差异。后两组在移植后第13天至第26天死亡。相反,整个A组持续存活且无腹水肿瘤迹象。然而,A组有一只动物在第28天后因腹壁出现实体瘤而死亡。